Harmony Biosciences Holdings, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
  • Harmony Biosciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $49.5M, a 85.9% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $145M, a 12.9% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $145M, a 12.9% increase from 2023.
  • Harmony Biosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $129M, a 29% decline from 2022.
  • Harmony Biosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $181M, a 425% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $145M +$16.6M +12.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $129M -$52.6M -29% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $181M +$147M +425% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $34.6M +$71.5M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$36.9M +$115M +75.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$152M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.